Skip to search.
 TSX Up 0.10% TSX Ventures Down 0.25%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
0.43 Down 0.00(1.12%) Apr 24, 3:59PM EDT
Add to Portfolio
Prev Close:0.44
Open:0.44
Bid:0.38 x 3000
Ask:0.47 x 4000
1y Target Est:4.00
Beta:2.54
Earnings Date:May 12 - May 18 (Est.)
Day's Range:0.43 - 0.44
52wk Range:0.40 - 1.75
Volume:381,225
Avg Vol (3m):459,287
Market Cap:12.27M
P/E (ttm):N/A
EPS (ttm):-0.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OPXADown 1.12%12.27M
SNYDown 0.02%135.32B
TEVAUp 1.83%54.87B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.51
Quarterly EPS Est (Mar-15) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases, such as neuromyelitis optica (NMO) based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback